Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators

Sponsor
Oregon Health and Science University (Other)
Overall Status
Completed
CT.gov ID
NCT01572246
Collaborator
Boston Scientific Corporation (Industry)
167
1
52.5
3.2

Study Details

Study Description

Brief Summary

This observational protocol will evaluate the effects of monopolar electrocautery (ME) on implantable cardioverter defibrillators (ICDs) in patients undergoing surgery. ME can cause electromagnetic interference (EMI) leading to ICD damage or inadvertent ICD discharge (shocks). Recommended practice calls for the preoperative reprogramming of ICDs when ME will be used to prevent patients from receiving inadvertent shocks. This requires the presence of someone trained in ICD programming, but a trained person is not always readily available.

In this study the investigators will reprogram ICDs prior to surgery according to current practice, but will also record what would have happened had the ICD reprogramming not occurred ("detection on" but "therapy off"). In addition, the investigators will evaluate the effect of the location of the electrosurgery unit (ESU) return pad on the incidence of EMI. The investigators hypothesize that directing the current return path away from the ICD will result in lower EMI rates than previously described.

Condition or Disease Intervention/Treatment Phase
  • Other: Optimal placement of return pad

Study Design

Study Type:
Observational
Actual Enrollment :
167 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Effects of Surgical Monopolar Electrocautery and Optimal Electrosurgery Unit Return Pad Placement on Implantable Cardioverter Defibrillators Protocol
Study Start Date :
May 1, 2012
Actual Primary Completion Date :
Sep 14, 2016
Actual Study Completion Date :
Sep 14, 2016

Arms and Interventions

Arm Intervention/Treatment
Non-cardiac above-the-waist surgery

Subjects with an implanted ICD who present for a non-cardiac above-the-waist surgical procedure involving monopolar electrocautery

Other: Optimal placement of return pad
The ESU return pad will be placed in an optimal position in order to direct ME current away from the ICD pulse generators.

Cardiac surgery

Subjects with an implanted ICD who present for a cardiac surgical procedure involving monopolar electrocautery

Below-the-waist surgery

Subjects with an implanted ICD who present for a below-the-waist surgical procedure involving monopolar electrocautery

Outcome Measures

Primary Outcome Measures

  1. Incidence of electromagnetic interference (EMI) [During surgery on day of enrollment]

    Evaluation of occurence of EMI when monopolar electrocautery is used in surgical procedures when the patient has an existing ICD.

Secondary Outcome Measures

  1. Incidence of unexpected preoperative ICD-related problems [Up to 6 months prior to date of surgery]

    Determine the incidence and nature of unexpected preoperative ICD-related problems, such as inadequate pacing or sensing thresholds, battery at or near elective replacement interval, and lead fracture, as detected by preoperative ICD interrogation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult individuals of both genders, 18 years of age and older

  • For patients undergoing surgery about the waist, previous implantation of a functioning Boston Scientific or Medtronic ICD

  • For patients undergoing surgery below the waist, previous implantation of a functioning Boston Scientific, Medtronic, St. Jude Medical, or Biotronik ICD

  • Signed informed consent

Exclusion Criteria:
  • Surgery involving the ICD pocket (generator change out procedure)

  • Surgery or procedures exclusively involving bipolar electrocautery (such as ophthalmic surgery)

  • Patients undergoing surgery above the waist with ICDs not manufactured by Medtronic or Boston Scientific (other ICDs do not allow reprogramming to allow EMI detection without the potential for inadvertent ICD discharge)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oregon Health & Science University Portland Oregon United States 97239

Sponsors and Collaborators

  • Oregon Health and Science University
  • Boston Scientific Corporation

Investigators

  • Principal Investigator: Peter Schulman, MD, Oregon Health and Science University
  • Principal Investigator: Charles Henrikson, MD, Oregon Health and Science University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Peter Schulman, Assistant Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT01572246
Other Study ID Numbers:
  • ISROTH20028
First Posted:
Apr 6, 2012
Last Update Posted:
Feb 24, 2017
Last Verified:
Aug 1, 2016
Keywords provided by Peter Schulman, Assistant Professor, Oregon Health and Science University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2017